Optometrist Amy Green discussed the importance of OCT in identifying AMD cases during the AOP’s Locum Clinical Skills ...
No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...
Money Talks News on MSN
Blind at 60. Vision restored at 61. Stanford research paves the way.
The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...
Retinal scans, aided by artificial intelligence (AI), may soon offer doctors a simple, non-invasive way to detect several ...
2don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...
In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, highlights data presented at Retina Subspecialty Day.
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...
Retinal microvascular changes detected by OCT-A may provide details for earlier diagnosis of coronary artery stenosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback